Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Medicine UCSF Medical Center
Home

Main navigation

  • About Us
    • Faculty
    • Finance and Administration
  • Clinical Services
    • Invasive Cardiology Services
    • Non-Invasive Cardiology Services
    • Cardiology Inpatient Services
    • Heart Failure Clinic
    • General Cardiology Clinic
    • Pacemaker and Device Clinic
    • Anticoagulation Clinic
    • Urgent Cardiology Clinic
  • Medical Education
    • Continuing Medical Education
    • Graduate Medical Education
    • Undergraduate Medical Education
  • Research
  • Giving

Menu Location

Zuckerberg San Francisco General
  • ZSFG Hospital
    Zuckerberg San Francisco General

    More than 2,000 UCSF physicians and staff work side-by-side with the dedicated employees of the San Francisco Department of Public Health.

  • SFVAMC
    San Francisco Veterans Affairs Health Care System

    UCSF medical students, residents and fellows rotate through the VA which provides nearly one third of all of the University's medical training.

  • UCSF Health
    UCSF Health

    The UCSF Medical Center is made up of three medical centers, at the Parnassus, Mount Zion and Mission Bay campuses.

Breadcrumb

  1. People
  2. Sithu Win, MD, MPH
Image of Sithu Win, MD, MPH
  • Send an Email

View UCSF Profile

Sithu Win, MD, MPH

Publications
  1. Thakkar AB, Durstenfeld MS, Ma Y, Win S, Hsue PY. Methamphetamine-associated heart failure: Clinical characteristics and outcomes in a safety net population. Heart & lung : the journal of critical care 2024. PMID: 39733607


  2. Chang A, Boyd A, Leung I, Trejo E, Dixit N, Mallidi J, Win S, Beatty AL. Formative research to adapt a cardiac rehabilitation program to breast cancer survivors: the heart health after cancer treatment (HEART-ACT) study. Cardio-oncology (London, England) 2024. PMID: 38760873


  3. Ravi A, Vittinghoff E, Wu AHB, Suen LW, Coffin PO, Hsue P, Lynch KL, Win S, Kazi DS, Riley ED. Cocaine Use is Associated With Increased LVMI in Unstably Housed Women With Polysubstance Use. Substance abuse 2023. PMID: 37830512


  4. Durstenfeld MS, Peluso MJ, Kaveti P, Hill C, Li D, Sander E, Swaminathan S, Arechiga VM, Sun K, Ma Y, Zepeda V, Lu S, Goldberg SA, Hoh R, Chenna A, Yee BC, Winslow JW, Petropoulos CJ, Win S, Kelly JD, Glidden DV, Henrich TJ, Martin JN, Lee YJ, Aras MA, Long CS, Grandis DJ, Deeks SG, Hsue PY. Inflammation during early post-acute COVID-19 is associated with reduced exercise capacity and Long COVID symptoms after 1 year. TO REMOVE 2022. PMID: 35677073


  5. Reddy YNV, Koepp KE, Carter R, Win S, Jain CC, Olson TP, Johnson BD, Rea R, Redfield MM, Borlaug BA. Rate-Adaptive Atrial Pacing for Heart Failure With Preserved Ejection Fraction: The RAPID-HF Randomized Clinical Trial. JAMA 2023. PMID: 36871285


  6. Sun K, Cedarbaum E, Hill C, Win S, Parikh NI, Hsue PY, Durstenfeld MS. Association of Right Ventricular Dilation on Echocardiogram with In-Hospital Mortality Among Patients Hospitalized with COVID-19 Compared with Bacterial Pneumonia. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2022. PMID: 36592874


  7. Sun K, Cedarbaum E, Hill C, Win S, Parikh NI, Hsue PY, Durstenfeld MS. Association of Right Ventricular Dilation and Dysfunction on Echocardiogram with In-Hospital Mortality Among Patients Hospitalized with COVID-19 Compared with Other Acute Respiratory Illness. medRxiv : the preprint server for health sciences 2022. PMID: 35794892


  8. Win S, Miranda-Schaeubinger M, Gustavo Durán Saucedo R, Carballo Jimenez P, Flores J, Mercado-Saavedra B, Camila Telleria L, Raafs A, Verastegui M, Bern C, Tinajeros F, Heymans S, Marcus R, Gilman RH, Mukherjee M, Chagas Working Group. Early identification of patients with Chagas disease at risk of developing cardiomyopathy using 2-D speckle tracking strain: Win, Miranda prediction of Chagas cardiomyopathy. TO REMOVE 2022. PMID: 35647262


  9. Garry JD, Thakkar AB, Durstenfeld MS, Ma Y, Win S, Hsue PY. Outcomes in Patients With Heart Failure Using Cocaine. TO REMOVE 2022. PMID: 35618544


  10. Durstenfeld MS, Peluso MJ, Kelly JD, Win S, Swaminathan S, Li D, Arechiga VM, Zepeda VA, Sun K, Shao SJ, Hill C, Arreguin MI, Lu S, Hoh R, Tai VW, Chenna A, Yee BC, Winslow JW, Petropoulos CJ, Kornak J, Henrich TJ, Martin JN, Deeks SG, Hsue PY. Role of antibodies, inflammatory markers, and echocardiographic findings in post-acute cardiopulmonary symptoms after SARS-CoV-2 infection. TO REMOVE 2022. PMID: 35389890


  11. Dewland TA, Whitman IR, Win S, Sanchez JM, Olgin JE, Pletcher MJ, Santhosh L, Kumar U, Joyce S, Yang V, Hwang J, Ogomori K, Peyser N, Horner C, Wen D, Butcher X, Marcus GM. Prospective arrhythmia surveillance after a COVID-19 diagnosis. TO REMOVE 2022. PMID: 35058344


  12. Malik N, Win S, James CA, Kutty S, Mukherjee M, Gilotra NA, Tichnell C, Murray B, Agafonova J, Tandri H, Calkins H, Hays AG. Right Ventricular Strain Predicts Structural Disease Progression in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy. TO REMOVE 2020. PMID: 32242475


  13. Win S, Hussain I, Hebl VB, Dunlay SM, Redfield MM. Inpatient Mortality Risk Scores and Postdischarge Events in Hospitalized Heart Failure Patients: A Community-Based Study. Volume 10 of Issue 7. Circulation. Heart failure 2017. PMID: 28701328


  14. Kristensen SL, Mogensen UM, Jhund PS, Petrie MC, Preiss D, Win S, Køber L, McKelvie RS, Zile MR, Anand IS, Komajda M, Gottdiener JS, Carson PE, McMurray JJ. Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Volume 135 of Issue 8. Circulation 2017. PMID: 28052977


  15. Carson PE, Anand IS, Win S, Rector T, Haass M, Lopez-Sendon J, Miller A, Teerlink JR, White M, McKelvie RS, Komajda M, Zile MR, McMurray JJ, Massie B. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction). JACC. Heart failure 2015. PMID: 25982110


  16. Oluleye OW, Rector TS, Win S, McMurray JJ, Zile MR, Komajda M, McKelvie RS, Massie B, Carson PE, Anand IS. History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction. Volume 7 of Issue 6. Circulation. Heart failure 2014. PMID: 25225241


  17. Koene RJ, Win S, Naksuk N, Adatya SN, Rosenbaum AN, John R, Eckman PM. HAS-BLED and CHA2DS2-VASc scores as predictors of bleeding and thrombotic risk after continuous-flow ventricular assist device implantation. Volume 20 of Issue 11. Journal of cardiac failure 2014. PMID: 25152496


  18. Anand IS, Win S, Rector TS, Cohn JN, Taylor AL. Effect of fixed-dose combination of isosorbide dinitrate and hydralazine on all hospitalizations and on 30-day readmission rates in patients with heart failure: results from the African-American Heart Failure Trial. Volume 7 of Issue 5. Circulation. Heart failure 2014. PMID: 24970468


  19. Win S, Parakh K, Eze-Nliam CM, Gottdiener JS, Kop WJ, Ziegelstein RC. Depressive symptoms, physical inactivity and risk of cardiovascular mortality in older adults: the Cardiovascular Health Study. Heart (British Cardiac Society) 2011. PMID: 21339320


UCSF Sublogo

 
© 2025 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Medicine                                                                  Accessibility  Privacy Policy  Terms of Use  A-Z Website List